Hanbon(688755.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Hanbon
688755.SH
Jiangsu Hanbon Science and Technology Co., Ltd. engages in the research and development, production, and sale of liquid chromatography products in China and internationally. The company offers biopharm purification equipment, including chromatography column products, chromatography systems, buffer dilution/conditioning systems, filtration systems, and single-use systems; bio-oligo synthesizer products, such as nucleic acid synthesizer and oligonucleotide synthesis column products; and preparative liquid chromatography system and chromatographic column products. It also provides continuous chromatographic systems comprising simulated moving bed and continuous Ion exchange chromatography products; and supercritical fluid chromatography products, including analytical supercritical fluid chromatography, SFC-dynamic axial compression column, and CO2 booster station products.
609.47 B
688755.SHMarket value -Rank by Market Cap -/-

Financial Score

27/01/2026 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking20/27
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE0.00%D
    • Profit Margin10.04%B
    • Gross Margin49.86%B
  • Growth ScoreB
    • Revenue YoY11.11%B
    • Net Profit YoY27.95%B
    • Total Assets YoY0.00%C
    • Net Assets YoY0.00%C
  • Cash ScoreB
    • Cash Flow Margin995.87%B
    • OCF YoY11.11%B
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreB
    • Gearing Ratio34.37%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Hanbon Technology: Net profit in the third quarter was 9.2196 million yuan, a year-on-year increase of 30.64%

    Hanbon Technology announced that its revenue for the third quarter was 157 million yuan, a year-on-year increase of 1.67%; net profit was 9.2196 million yuan, a year-on-year increase of 30.64%. Revenue for the first three quarters was 506 million yuan, a year-on-year increase of 4.61%; net profit was 37.0172 million yuan, a year-on-year decrease of 17.27%

    Zhitong·
    SH
    688755
    -0.90%
    Zhitong·
    SH
    688755
    -0.90%

    Hanbon Technology: Net profit of 27.7976 million yuan in the first half of 2025, a year-on-year decrease of 26.24%

    Hanbon Technology announced that its operating revenue in the first half of 2025 is 349 million yuan, a year-on-year increase of 5.99%. Net profit is 27.7976 million yuan, a year-on-year decrease of 26.24%

    Zhitong·
    SH
    688755
    -0.90%
    Zhitong·
    SH
    688755
    -0.90%

    The medical device industry receives significant benefits, and the list of high-growth overseas business revenue is released

    The National Medical Products Administration has drafted the "Regulations on the Management of Export Sales Certificates for Medical Devices" to support the export trade of medical device products. In the A-share medical device industry, 117 companies are expected to generate a total overseas revenue of 81.366 billion yuan in 2024, a year-on-year increase of 16.21%. Mindray has the highest overseas revenue, reaching 16.434 billion yuan, with a growth rate of 21.28%. Hanbon Technology, Endovastec, and Chunli Medical have overseas revenue growth rates of 103.52%, 99.35%, and 78.31%, respectively

    Zhitong·
    SH
    688236
    -3.04%
    HK
    01858
    -1.85%
    SZ
    300760
    -1.51%
    Zhitong·
    SH
    688236
    -3.04%
    HK
    01858
    -1.85%
    SZ
    300760
    -1.51%

    After a break, we set off again. The "new share subscription" strategy continues to be profitable!

    The A-share market welcomes new stock listings, and investors remain optimistic about the "new share subscription" strategy. Tiangong Co., Ltd. saw a first-day increase of 411.93%, while Hanbon Technology and ZERUN New Energy also performed well, with single-sign profits of 12,950 yuan and 17,430 yuan, respectively. Next week, GUQI will be listed, focusing on down products, with stable performance but high customer concentration

    Wallstreetcn·
    SZ
    301636
    -0.93%
    SH
    688755
    -0.90%
    SZ
    001390
    -1.30%
    Wallstreetcn·
    SZ
    301636
    -0.93%
    SH
    688755
    -0.90%
    SZ
    001390
    -1.30%

    WuXi AppTec's invested company Hanbon Technology was listed on the Shanghai Stock Exchange on May 16

    According to the Zhitong Finance APP, WuXi AppTec announced that its affiliated company Jiangsu Hanbon Technology Co., Ltd. (hereinafter referred to as "Hanbon Technology") will be listed on the Shanghai Stock Exchange on May 16, 2025. The company indirectly holds 5.313131 million shares of Hanbon Technology, accounting for 6.04% of its total share capital after the completion of the initial public offering

    Zhitong·
    SH
    688755
    -0.90%
    Zhitong·
    SH
    688755
    -0.90%
    © 2026 Longbridge｜Disclaimer